Navigation Links
Australian State Approves Therapeutic Cloning

Lawmakers in Australia's most populous state voted Thursday to overturn a ban on the use of cloned human embryos for stem cell research despite strong opposition from the Catholic church.

Controversial new legislation allowing therapeutic cloning was passed in New South Wales by 65 votes to 26. The legislation needs to be approved by the upper house of the state parliament before becoming law.

It will allow researchers to clone human embryos to extract stem cells in the hope of one day finding cures for debilitating diseases such as Alzheimer's, Parkinson's and cystic fibrosis.

The head of the Catholic church in Australia, Sydney Archbishop Cardinal George Pell, caused outrage after warning Catholic lawmakers they faced "consequences" if they voted in favour of the legislation.

Several Catholic members of parliament, led by State Premier Morris Iemma, said they would defy Pell and approve the law in the hope that it could lead to medical breakthroughs.

Pell indicated he was considering refusing holy communion to lawmakers who did not toe the line but stopped short of threatening to excommunicate them.

The archbishop was roundly condemned both within and outside parliament for what lawmakers described as unacceptable interference in politics.


'"/>




Page: 1

Related medicine news :

1. Australian Scientists Silence Cancer Gene
2. Australian Government To Stockpile Anti-Bird Flu Drug Relenza
3. Australian Company Gets $10 million For Developing Skin Cancer Gel
4. Australian Health funds stand accused
5. Australian Court Finds Man Guilty of Spreading HIV/AIDS
6. Australian Scientists Develop Novel Drug To Combat Inflammatory Diseases
7. Sale Of Bird Flu Vaccine to US Planned: Australian Firm
8. Hepatitis C Could Infect 800,000 Australians By 2020
9. Obesity Cost More Than The Australian Health Budget
10. Australian Snake Venom Can Arrest Bleeding During Surgery And Trauma
11. Fat Virus, Ad-36 Blamed For Obesity Epidemic In Australians
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/6/2016)... ... December 06, 2016 , ... TopConsumerReviews.com recently gave a best-in-class 5 star rating ... Scooters give freedom to people who need help getting around. For some, advancing age ... long period of rehabilitation after an illness or accident. There is a wide variety ...
(Date:12/6/2016)... ... December 06, 2016 , ... "Add realistic flares and ... flash, and flare from clip to clip with high quality 4K lens flare footage," ... Jewel contains 44 lens flares filmed on the RED Dragon. Utilizing the Dragon Sensor, ...
(Date:12/5/2016)... ... December 05, 2016 , ... What: Shriners Hospitals for Children, with ... to our patients – using a video monitor and web-enabled camera. Santa visits with ... the Auditorium into a Christmas Wonderland, which is where the video connection to the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Surgery, is excited to announce the arrival of the newest Sciton laser in ... the ability to use tunable non-ablative and ablative wavelengths for exceptional results. Outperforming ...
(Date:12/5/2016)... ... December 06, 2016 , ... For many years, ... , both thick and thin. The beauty of the Lithuanian language and ... , In this poetry book, Zubinas lyrically explores all aspects of a living, breathing ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... Dec. 5, 2016   Mallinckrodt Pharmaceuticals (NYSE: ... company, today announced that it received a perfect score ... (CEI), a national benchmarking survey and report on corporate ... transgender (LGBT) workplace equality, administered by the Human Rights ... major U.S. businesses which also earned top marks this ...
(Date:12/5/2016)... , Dec. 5, 2016 Special purpose needles are ... such as fluid and cells from organs or lumps and ... and sizes. The global market for special purpose needles is ... In terms of revenue, the global special purpose needles market ... the forecast period (2016–2026) and is expected to be valued ...
(Date:12/5/2016)...   Lexicon Pharmaceuticals, Inc. (Nasdaq: ... 2 clinical study of sotagliflozin, a dual SGLT1 and ... the leading global organization funding type 1 diabetes research. ... trial, which randomized a total of 87 patients, was ... dose of sotagliflozin compared to a placebo control in ...
Breaking Medicine Technology: